首页> 外文期刊>Japanese Journal of Ophthalmology >Photodynamic therapy with delayed light application for the treatment of bilateral subfoveal choroidal neovascularization in age-related macular degeneration.
【24h】

Photodynamic therapy with delayed light application for the treatment of bilateral subfoveal choroidal neovascularization in age-related macular degeneration.

机译:延迟光应用光动力疗法治疗年龄相关性黄斑变性中的双侧凹下脉络膜新生血管。

获取原文
获取原文并翻译 | 示例
       

摘要

To determine if photodynamic therapy (PDT) with delayed light application at 17 minutes after the start of infusion was effective in the second eyes of patients with bilateral subfoveal classic choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD).The records of 20 patients with bilateral subfoveal classic CNV secondary to AMD who were treated with bilateral PDT in the same session were reviewed. Treatment for the second eye of patients was begun 120 seconds after termination of treatment for the first eye. This time interval was necessary for applying the contact lens and entering the new laser parameters, and it was kept constant in all cases. Best-corrected visual acuity (BCVA), ophthalmologic examinations, fluorescein and indocyanine angiograms were used to evaluate the results of PDT. Follow-up time ranged from 6 to 12 months with a mean of 8.7 (+/-2.1) months.Mean (+/-SD) treatment sessions were 1.7 (+/-0.6) in first eyes and 1.7 (+/-0.5) in second eyes. Among first eyes, BCVA improved in 7 of the 20 eyes (35%); stabilized in 7 eyes (35%); and worsened in 6 eyes (30%). Among second eyes, BCVA improved in 5 of the 20 eyes (25%); stabilized in 8 eyes (40%); and worsened in 7 eyes (35%).In most cases, bilateral PDT in the same session achieved cessation of fluorescein leakage from CNV without loss of vision or growth of CNV in the second eyes of patients with bilateral subfoveal classic CNV secondary to AMD. Further studies with a larger number of patients and longer follow-up are necessary to confirm whether bilateral PDT in the same session is beneficial for bilateral subfoveal classic CNV related to AMD.
机译:为了确定输注开始后17分钟延迟应用光动力疗法(PDT)是否对继发于年龄相关性黄斑变性(AMD)的双侧黄斑下侧经典脉络膜新生血管(CNV)患者的第二只眼有效。回顾了在同一疗程中接受双侧PDT治疗的20例继发于AMD的双侧凹下经典CNV患者。对第一只眼的治疗终止后120秒开始对患者的第二只眼进行治疗。这个时间间隔对于应用隐形眼镜和输入新的激光参数是必要的,并且在所有情况下都保持恒定。最佳矫正视力(BCVA),眼科检查,荧光素和吲哚菁血管造影照片用于评估PDT结果。随访时间为6到12个月,平均8.7(+/- 2.1)个月。平均(+/- SD)治疗疗程为第一只眼1.7(+/- 0.6)和1.7(+/- 0.5) )。在第一只眼中,BCVA在20只眼中的7只眼中得到了改善(35%)。稳定在7眼(35%);并有6眼恶化(30%)。在第二只眼中,BCVA在20只眼中的5只眼中得到了改善(25%)。稳定在8眼(40%);并恶化了7眼(35%)。在大多数情况下,在同一疗程中双侧PDT能够停止CNV的荧光素渗漏,而在继发于AMD的双侧凹下经典CNV患者的第二只眼中,其视力不会丧失或CNV不会增长。有必要对更多的患者进行进一步的研究,并进行更长的随访,以确认同一疗程中的双侧PDT是否对与AMD相关的双侧凹下经典CNV有益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号